Medical-equipment maker Medtronic (NYSE: MDT) reports its fiscal second-quarter 2008 earnings results just on the other side of this weekend. Want to know what Wall Street expects to see? Read on. Want to know what really matters? Read on a bit more.
What analysts say:
- Buy, sell, or waffle? Twenty-nine analysts take the pulse of Medtronic, giving the stock 18 buy ratings and 11 holds.
- Revenue. Wall Street expects to see sales rise less than 1% to $3.1 billion.
- Earnings. Profits are predicted to fall 5% to $0.56 per share.
read the full article: http://www.fool.com/investing/high-growth/2007/11/15/foolish-forecast-mulling-medtronic.aspx
No comments:
Post a Comment